Effect of food on the pharmacokinetics of delayed-release valproate in healthy human subjects.

被引：0
|
作者：
Nangia, A
Cullen, E
Niecestro, R
Friedhoff, L
机构：
[1] Andrx Pharmaceut, Ft Lauderdale, FL USA
[2] Andrx Labs, Hackensack, NJ USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2003年 / 43卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
78
引用
收藏
页码：1032 / 1032
页数：1
相关论文
共 50 条
  • [21] Tolerability and Pharmacokinetics of Delayed-Release Dimethyl Fumarate Administered With and Without Aspirin in Healthy Volunteers
    Sheikh, Sarah I.
    Nestorov, Ivan
    Russell, Heidy
    O'Gorman, John
    Huang, Ron
    Milne, Ginger L.
    Scannevin, Robert H.
    Novas, Mark
    Dawson, Katherine T.
    CLINICAL THERAPEUTICS, 2013, 35 (10) : 1582 - 1594
  • [22] Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects
    Kim, Hyun Chul
    Yang, Eunsol
    Ban, Mu Seong
    Kim, Yu Kyong
    Hong, Sung Hee
    Jung, Jina
    Jang, In-Jin
    Lee, SeungHwan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 1115 - 1124
  • [23] Pharmacokinetics of extended-release metformin versus immediate-release metformin in healthy subjects.
    Niecestro, RM
    Lukacsko, P
    Lamson, MJ
    Walters, E
    Freidhoff, LT
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1063 - 1063
  • [24] LY451395 cerebrospinal fluid pharmacokinetics in healthy human subjects.
    Jhee, S
    Chalon, S
    Toublanc, N
    Brandt, J
    Chappell, A
    Shiovitz, TS
    Farrar, S
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1067 - 1067
  • [25] Cerebrospinal fluid pharmacokinetics of LY450108 in healthy human subjects.
    Jhee, SS
    Chalon, S
    Cleton, A
    Brandt, JE
    Chappell, AS
    Francisco, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P8 - P8
  • [26] The pharmacokinetics of tesaglitazar (GALIDA™) in healthy male subjects.
    Ericsson, H
    Samuelsson, S
    Bergstrand, S
    Fryklund, L
    Hamrén, B
    Heijer, M
    Öhman, P
    DIABETOLOGIA, 2003, 46 : A292 - A292
  • [27] Pharmacokinetics of Tapentadol in Healthy Elderly and Young Subjects.
    Smit, J. W.
    Haeufel, T.
    Ravenstijn, P.
    Brett, M.
    Kleideiter, E.
    Mangold, B.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1079 - 1079
  • [28] Effect of asoprisnil on the pharmacokinetics of triazolam and its metabolite in healthy female subjects.
    Lee, RD
    Mulford, D
    Witt, G
    Chwalisz, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P79 - P79
  • [29] Effect of food on the pharmacokinetics of osmotic controlled-release methylphenidate HCl in healthy subjects
    Modi, NB
    Wang, B
    Hu, WT
    Gupta, SK
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2000, 21 (01) : 23 - 31
  • [30] THE EFFECT OF EVEROLIMUS (EVE) ON THE PHARMACOKINETICS (PK) OF MIDAZOLAM (MID) IN HEALTHY SUBJECTS.
    Urva, S.
    Bouillaud, E.
    Delaney, R.
    Jappe, A.
    Cheung, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S128 - S128
12345